Skip to main content
News BMZ II

News categories: Honors & Funding

ImmunoSensation members among "highly cited researchers"

Five scientists from ImmunoSensation2 are among the world's most cited researchers, annualy published by the information service provider Clarivate Analytics. Once more, Prof. Joachim Schultze (DZNE), Prof. Andreas Schlitzer (LIMES) and Prof. Eicke Latz (DRFZ), Prof. Jonathan Schmid-Burgk (UKB) and Thomas Bieber (UKB) are part of the impressive list.

According to the compilers of the ranking, the people on this list of ‘Highly Cited Researchers’ are among the world's most influential one per cent in their field. The list contains around 6,600 researchers from 59 countries. From Germany, 332 researchers have made it onto the list - including ten from the University of Bonn


The benchmark is the frequency with which scientific publications have been cited by other researchers in the last ten years (period from 2013 to 2023). For the analysis, the creators of the list divided the publications into 20 subject areas and introduced the ‘Cross-Field’ section, which lists researchers who have published in several subject areas.

The ranking is published annually by the ‘Web of Science Group’ and can be found here.

 

Related news

Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

—Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).
View entry
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern,
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern, - Direktorin des Instituts für Zelluläre Neurowissenschaften II am UKB, sind Sprecher und stellvertretende Sprecherin der neuen DFG-Forschungsgruppe FOR 5987. Der Forschungsverbund untersucht, wie Botenstoffe Informationen im Gehirn innerhalb und außerhalb von Synapsen übertragen.

News categories: Honors & Funding

How Far Do Signalling Molecules Act Beyond the Boundaries of a Synapse?

—The German Research Foundation (DFG) is establishing a new Research Unit entitled “Inside and Outside the Synapse: Challenging Dogmas of Synaptic Signalling and Neuromodulation.” The research consortium is headed by Prof. Christian Henneberger from Bonn University Hospital (UKB) and the University of Bonn, with Prof. Susanne Schoch McGovern, also from the UKB and the University of Bonn. Together with researchers from the UKB, the University of Bonn, the DZNE and the University of Göttingen, they will investigate how signalling molecules transmit information in the brain.
View entry
Sieglinde Tyczka und Frederick Tyczka-Christoph zu Besuch in der Bonner Universitäts-Augenklinik. - von links: Prof. Dr. Uwe Reuter, Vorstandsvorsitzender und Ärztlicher Vorstand des UKB, Frederick Tyczka-Christoph, Sieglinde Tyczka, Prof. Dr. Frank G. Holz, Direktor der Augenklinik am UKB.

News categories: Honors & Funding

One Million Euros for Restoring Vision in Age-Related Macular Degeneration

—The Tyczka family of entrepreneurs is supporting research into restoring vision in patients with age-related macular degeneration (AMD) with a donation of one million euros. The funding will support the research project “AI-supported optimisation of vision restoration using retinal implants” at the Department of Ophthalmology at Bonn University Hospital (UKB). The aim of the project is to further develop and optimise the application of innovative retinal implant technology, which recently received European CE marking as a medical device.
View entry

Back to the news overview